相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A potential objective marker in first-episode schizophrenia based on abnormal niacin response
YeGang Hu et al.
SCHIZOPHRENIA RESEARCH (2022)
Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics
Marc-Andre Nolin et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2021)
Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug na?ve first-episode schizophrenia
Dachun Chen et al.
PSYCHIATRY RESEARCH (2021)
Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings
Naomichi Okamoto et al.
FRONTIERS IN PSYCHIATRY (2021)
Evaluation of IGF-1 as a novel theranostic biomarker for schizophrenia
Umit Haluk Yesilkaya et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
The role of dopamine receptors in lymphocytes and their changes in schizophrenia
M. A. Penedo et al.
BRAIN, BEHAVIOR, & IMMUNITY - HEALTH (2021)
The association between serum insulin-like growth factor 1 and cognitive impairments in patients with schizophrenia
Chao Xue-lin et al.
PSYCHIATRY RESEARCH (2020)
Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia
Yuan-Jian Yang et al.
PLOS ONE (2020)
Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics
Xue-lin Chao et al.
CURRENT MEDICAL SCIENCE (2020)
Risk of Dementia in persons who have previously experienced clinically-significant Depression, Anxiety, or PTSD: A Systematic Review and Meta-Analysis
J. K. Kuring et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Disorders of IGFs and IGF-1R signaling pathways
Briony E. Forbes et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Association between Serum Lipids and Antipsychotic Response in Schizophrenia
David D. Kim et al.
CURRENT NEUROPHARMACOLOGY (2019)
Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality
Jeffrey A. Lieberman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Non-Genetic Factors in Schizophrenia
Simona A. Stilo et al.
CURRENT PSYCHIATRY REPORTS (2019)
Insulin growth factor 2 (IGF2) as an emergent target in psychiatric and neurological disorders. Review
M. Pardo et al.
NEUROSCIENCE RESEARCH (2019)
IGF-binding proteins
L. A. Bach
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Insulin-Like Growth Factor (IGF) System in Liver Diseases
Agnieszka Adamek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
World leaders describe the latest in IGF research
Emily Jane Gallagher et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia
Alireza Mohammadi et al.
PSYCHIATRY RESEARCH (2018)
Current Concepts and Treatments of Schizophrenia
Piotr Stepnicki et al.
MOLECULES (2018)
Schizophrenia: A review of potential biomarkers
Daniela Rodrigues-Amorim et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia
Roberto Carlos Agis-Balboa et al.
EMBO JOURNAL (2017)
Depression as a risk factor for Alzheimer's disease: Genes, steroids, cytokines and neurogenesis - What do we need to know?
Joe Herbert et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2016)
Gene expression elucidates functional impact of polygenic risk for schizophrenia
Menachem Fromer et al.
NATURE NEUROSCIENCE (2016)
Elevated levels of Insulin-like Growth Factor-1 (IGF-1) in drug-naive patients with psychosis
Petros Petrikis et al.
PSYCHIATRY RESEARCH (2016)
Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics
Chi-Yu Lai et al.
WORLD JOURNAL OF PSYCHIATRY (2016)
Insulin-like growth factor binding-protein-3 (IGFBP-3)
Michael B. Ranke
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Late-Life Psychosis: Diagnosis and Treatment
Michael M. Reinhardt et al.
CURRENT PSYCHIATRY REPORTS (2015)
Serum IGFBP7 levels associate with insulin resistance and the risk of metabolic syndrome in a Chinese population
Yi Liu et al.
SCIENTIFIC REPORTS (2015)
Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naive depressive patients treated with antidepressant medication
Tania Rivera-Baltanas et al.
ANNALS OF GENERAL PSYCHIATRY (2015)
Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance
Sahitya K. Denduluri et al.
GENES & DISEASES (2015)
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease
Daniel Aberg et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Generating new neurons to circumvent your fears: the role of IGF signaling
R. C. Agis-Balboa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Relationships between IGF-1, schizophrenia, and treatment of metabolic syndrome
Aysegul Demirel et al.
COMPREHENSIVE PSYCHIATRY (2014)
Insulin growth factor binding protein 7 is a novel target to treat dementia
Hope Y. Agbemenyah et al.
NEUROBIOLOGY OF DISEASE (2014)
Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients
Aitor Palomino et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Symptom severity scale of the DSM5 for schizophrenia, and other psychotic disorders: diagnostic validity and clinical feasibility
Michael S. Ritsner et al.
PSYCHIATRY RESEARCH (2013)
Definition and description of schizophrenia in the DSM-5
Rajiv Tandon et al.
SCHIZOPHRENIA RESEARCH (2013)
Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without type 2 diabetes
Harvest F. Gu et al.
CLINICAL EPIGENETICS (2013)
Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia
Y. Hwang et al.
TRANSLATIONAL PSYCHIATRY (2013)
Neurodevelopmental effects of insulin-like growth factor signaling
John O'Kusky et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2012)
Insulin-like growth factors in the brain and their potential clinical implications
Eduardo E. Benarroch
NEUROLOGY (2012)
A hippocampal insulin-growth factor 2 pathway regulates the extinction of fear memories
Roberto Carlos Agis-Balboa et al.
EMBO JOURNAL (2011)
Insulin and insulin-like growth factor-1 abnormalities in anti psychotic-naive schizophrenia
Ganesan Venkatasubramanian et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder
Paula V. Nunes et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
The Basel early-detection-of-psychosis (FEPSY)-study -: design and preliminary results
A. Riecher-Roessler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects
Abayomi O. Akanji et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
The effect of clozapine on factors controlling glucose homeostasis
OD Howes et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts
M Atmaca et al.
ACTA PSYCHIATRICA SCANDINAVICA (2003)
分享论文
